Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

579
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
579
Effects of Chemicals: Overview01:27

Effects of Chemicals: Overview

2.5K
Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
2.5K
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

681
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
681
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

85
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
85
Framing Effects03:26

Framing Effects

8.1K
Information is everywhere and its presentation—such as how and when items are presented—can impact our perceptions and decisions surrounding the info. This broad concept umbrellas framing effects—influences that occur due to the way information is framed in its appearance, whether it’s purely the order or the specific wording of a message. Let’s take a look at numerous ways in which two versions of something can objectively say the same thing, yet we respond in...
8.1K
Drug Regulation01:25

Drug Regulation

3.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longevity of modern pesticides in Swiss agricultural soils: distribution, drivers, and potential environmental implications.

Environmental science. Processes & impacts·2026
Same author

Why BCF values from high test concentrations underestimate bioaccumulation - Reply to the comment by Ebert et al.

Journal of hazardous materials·2026
Same author

Cryogenically milled tire tread induces functional and structural changes in natural periphyton communities.

Environmental pollution (Barking, Essex : 1987)·2026
Same author

Effects of Pesticide Mixtures and Environmental Factors on Benthic Diatom Communities: A Microcosm Approach.

Environmental science & technology·2026
Same author

Benchmarking environmental risks of plant protection products: Toward a comparative and systems-based approach in the EU pesticide regulation.

Environment international·2026
Same author

Advancing environmental risk assessment (ERA) of plant protection products through a systems-based approach to strengthen biodiversity protection.

Environment international·2025

Related Experiment Video

Updated: Apr 17, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

14.8K

One Substance, Multiple Assessments: How the various European Environmental Risk Frameworks affect the outcome of

Alexandra Kroll1, Annette Aldrich2, Sandrine Andres3

  • 1Swiss Centre for Applied Ecotoxicology, Dübendorf, Switzerland.

Integrated Environmental Assessment and Management
|April 16, 2026
PubMed
Summary

The European Union

Keywords:
FAIRenvironmental risk assessmentharmonizationone substance–one assessmentpesticides

More Related Videos

Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays
08:00

Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays

Published on: December 4, 2016

8.0K
Analysis of Organochlorine Pesticides in a Soil Sample by a Modified QuEChERS Approach Using Ammonium Formate
04:17

Analysis of Organochlorine Pesticides in a Soil Sample by a Modified QuEChERS Approach Using Ammonium Formate

Published on: January 20, 2023

4.1K

Related Experiment Videos

Last Updated: Apr 17, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

14.8K
Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays
08:00

Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays

Published on: December 4, 2016

8.0K
Analysis of Organochlorine Pesticides in a Soil Sample by a Modified QuEChERS Approach Using Ammonium Formate
04:17

Analysis of Organochlorine Pesticides in a Soil Sample by a Modified QuEChERS Approach Using Ammonium Formate

Published on: January 20, 2023

4.1K

Area of Science:

  • Environmental chemistry
  • Chemical risk assessment
  • Regulatory science

Background:

  • European Union (EU) chemical regulations vary by substance use, leading to environmental protection inconsistencies.
  • Advances in chemical monitoring reveal disparities in environmental risk assessments.
  • The European Commission advocates for a "one substance, one assessment" (OS-OA) approach.

Purpose of the Study:

  • To examine the implementation and outcomes of environmental risk assessments across different EU regulatory frameworks.
  • To identify methodological differences impacting the "one substance, one assessment" (OS-OA) approach.
  • To analyze case studies on imidacloprid and deltamethrin in the aquatic environment.

Main Methods:

  • Comparative analysis of environmental risk assessments under different regulatory frameworks.
  • Case study analysis using imidacloprid and deltamethrin.
  • Evaluation of data consistency, incorporation of new scientific data, and analytical sensitivities.

Main Results:

  • Significant inconsistencies found in data used across different regulatory risk assessments.
  • New scientific data is not consistently integrated, prolonging environmental risks.
  • Low analytical sensitivity in monitoring hinders risk assessment comparisons.

Conclusions:

  • Divergent outcomes in risk assessments for the same substance due to differing data, models, and protection goals.
  • Read-across of hazard assessments is recommended to address data gaps and improve regulatory efficiency.
  • Coherent regulation and standardized risk assessment methods are crucial for enhanced EU environmental protection.